Most clinical trials have tested citicoline for 4 to 12 weeks, with longer studies running 9 to 12 months. The right duration depends entirely on why you’re taking it. Someone using citicoline for sharper focus may only need a few months, while someone managing age-related cognitive decline or glaucoma may benefit from continuous or cyclical use over years. Here’s what the research actually shows for each situation.
For Focus and Memory in Healthy Adults
If you’re a generally healthy person looking for a cognitive edge, the typical study window is 4 to 12 weeks at doses of 250 to 500 mg per day. In one trial, 500 mg daily for just two weeks improved vigilance and working memory in 40 healthy volunteers. A study in teenage males found that 250 to 500 mg for four weeks improved speed and attention. The most rigorous trial design for this purpose, a randomized, double-blind, placebo-controlled study in healthy adults, used a 12-week treatment period.
For older adults specifically, a trial in people ages 50 to 85 with age-related memory complaints tested 500 mg daily for 12 weeks. So if you’re supplementing for general sharpness, a 12-week course is a reasonable starting point. You can then reassess whether you notice a difference.
For Cognitive Decline and Dementia
When citicoline is used for more serious cognitive concerns, the timelines stretch considerably. Studies in people with vascular cognitive impairment or dementia have run 9 to 12 months, and the results suggest that longer is generally better.
In a trial of 349 patients with vascular cognitive impairment, nine months of citicoline at 1,000 mg daily produced a meaningful difference in cognitive scores compared to placebo. A 12-month observational study in 81 people with vascular risk factors and early cognitive complaints used 1,000 mg daily for the full year. Several large studies combining citicoline with standard dementia medications ran for 9 to 12 months and found that the combination slowed cognitive decline more than medications alone. In one 12-month study of 126 patients with Alzheimer’s or mixed dementia, those taking a standard medication alone saw their cognitive scores drop by about 1.6 points, while those who added citicoline actually improved by about 1 point.
The pattern across these trials is clear: benefits build over months, not days. Pilot studies testing just 1 to 3 months at 1,000 mg daily showed only modest improvements (around 1 point on standard cognitive tests). The larger, longer trials showed more meaningful effects. If you’re taking citicoline for age-related cognitive concerns, plan for at least 6 months before drawing conclusions, and ongoing use may be warranted.
For Stroke Recovery
A major pooled analysis published in the journal Stroke examined data from multiple clinical trials of citicoline after ischemic stroke. The standard treatment period across these trials was 6 weeks, with outcomes measured at 3 months. A separate study found that starting citicoline within 24 hours of a stroke and continuing for 6 months was safe and helped prevent cognitive impairment that commonly follows stroke. Extending treatment to 12 months showed continued improvement in areas like orientation, executive function, and attention, with excellent tolerability throughout.
For Glaucoma and Eye Health
Citicoline has been studied as a nerve-protective supplement for glaucoma, and the research here reveals something important about how the compound works: its effects fade when you stop taking it.
In one study, patients who took citicoline for 3 months showed measurable improvement in retinal nerve fiber thickness. After just one month off the supplement, that improvement partially reversed. Another trial using citicoline eye drops for 4 months found significant gains in visual processing, but after a 2-month break, those gains disappeared entirely. This pattern repeated across multiple glaucoma studies: benefits appeared during treatment and regressed during washout periods.
Because of this, researchers have concluded that continuous or cyclical administration is necessary for sustained neuroprotective effects. The most common cycling protocol tested was 120 days on, followed by a 60-day break, repeated over 2 years. This schedule slowed the thinning of the retinal nerve fiber layer and improved visual fields. Another approach used two 6-month treatment periods with a 3-month break in between. For glaucoma, citicoline is not a short course. It’s an ongoing commitment.
What Happens When You Stop
The glaucoma research offers the clearest picture of what happens after discontinuation, and the news is mixed. Benefits don’t persist indefinitely once you stop. Citicoline supports the production of key components in cell membranes and helps maintain levels of certain brain chemicals, but it doesn’t permanently change your brain’s baseline. Think of it less like a repair and more like ongoing nutritional support. When the supply stops, the extra support gradually fades.
No withdrawal symptoms have been reported in any of the clinical trials. Citicoline is remarkably well tolerated. In fact, across multiple large studies, more side effects were reported in the placebo groups than in the citicoline groups. The concern isn’t about feeling worse when you stop; it’s simply that the cognitive or neuroprotective benefits may gradually return to your pre-supplement baseline.
Continuous Use vs. Cycling
The research supports two approaches: continuous daily use or a cycling protocol. Most cognitive studies used continuous daily dosing for their full duration (up to 12 months). Glaucoma research tested both methods and found cycling effective, specifically 4 months on and 2 months off.
Continuous use has been safely studied for up to 12 months at doses of 1,000 mg per day. No safety concerns emerged in any of these longer trials. The effective dose range across all conditions is 500 to 1,000 mg daily, with most studies using either 500 mg or 1,000 mg. There’s no evidence that higher doses require shorter treatment periods or that lower doses need to be taken longer to work.
For a healthy person supplementing for focus, a 12-week block is a solid trial period. For anyone dealing with cognitive decline, post-stroke recovery, or glaucoma, the evidence points toward 6 to 12 months minimum, with many people benefiting from ongoing or cyclical use well beyond that window.